Twist Bioscience (TWST) Form 144 Filed for 892-Share Sale

Rhea-AI Filing Summary

The filing is a Form 144 notice for Twist Bioscience Corporation (TWST) reporting a proposed sale of 892 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $22,977.83 and an approximate sale date of 09/08/2025. The shares were acquired on 09/05/2025 by restricted stock vesting and paid as compensation. The filer discloses four prior sales by the same person between 06/20/2025 and 08/21/2025, totaling 2,308 shares with combined gross proceeds shown. The notice includes the required statement that the seller is not aware of undisclosed material adverse information.

Positive

• Compliance: The filing provides required Rule 144 details including acquisition method, broker, and planned sale date.
• Transparency: The seller attests they have no undisclosed material adverse information and lists recent sales in the prior three months.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Form 144 reporting an insider sale tied to recently vested restricted stock; no disclosure of undisclosed material adverse information.

The filing documents a proposed open-market sale of 892 common shares acquired by restricted stock vesting and designated as compensation. The sale is to be executed through Fidelity on NASDAQ on or about 09/08/2025. Prior sales by the same seller during the last three months are listed with dates, amounts, and gross proceeds, showing ongoing dispositions of vested shares. There are no statements in the filing indicating material undisclosed information about the issuer.

Corporate Governance Expert

TL;DR: Filing appears compliant with Rule 144 disclosure requirements and includes the seller's attestation regarding material information.

The notice provides the required details: acquisition date (09/05/2025), nature of acquisition (restricted stock vesting), payment as compensation, broker information, and the issuer's outstanding share count. It also includes a signature attestation about absence of undisclosed material adverse information and references trading-plan representation language. This is a routine insider reporting disclosure rather than a governance event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	892	22977.83	60360925	09/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2025	Restricted Stock Vesting	Issuer			892	09/05/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	06/20/2025	292	10440.37
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	07/02/2025	142	5139.42
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	08/04/2025	1255	35596.95
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	08/21/2025	619	16071.84

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TWST Form 144 report say about the proposed sale?

The notice reports a proposed sale of 892 common shares through Fidelity with an aggregate market value of $22,977.83 and an approximate sale date of 09/08/2025.

How were the shares that are being sold acquired?

The shares were acquired on 09/05/2025 through restricted stock vesting and payment is recorded as compensation.

Has the seller recently sold other TWST shares?

Yes. The filing lists four prior sales by the same person between 06/20/2025 and 08/21/2025, totaling 2,308 shares with gross proceeds shown for each sale.

Which broker and exchange are named for the proposed sale?

The sale is to be executed through Fidelity Brokerage Services LLC and the securities exchange listed is NASDAQ.

Does the filing disclose any undisclosed material adverse information?

The filer signs an attestation representing that they do not know of any material adverse information about the issuer that has not been publicly disclosed.